Below is the relevant legislation related to parity that has been introduced during the current or recently adjourned legislative session. State parity legislation passed in any state since 2008 is usually designed to increase compliance with the federal law and to strengthen state laws.
Regular Session: Convened 1/8/2019 Will Adjourn: 1/14/2020 Governors’ Deadline: 1/25/2020
Primary Focus: Medical Management limitation Title/Description: An Act Regarding the Process for Obtaining Prior Authorization for Health Insurance Purposes Citation: HB 220 Introduced: 6/13/2019 Sponsor: Rep. Bent(D) and Sen. Towsend (D) Status: Signed into law Summary: HB 220 amends section 3343, Title 18 and section 3571V, Title 18 of the Delaware Code by requiring health benefit plans that cover prescription drugs to place at least one formulation of each of the FDA-approved MAT drugs on the lowest tier of the carrier’s prescription drug formulary. Such drugs must be covered without prior authorization. Additionally, the bill requires that at least one formulary of each medication within each tier be available without step-therapy requirements. Finally, plans must provide coverage for fees associated with the dispensing and administration of methadone at opioid treatment programs Notes: N/A
Summary: This bill tried to change the state insurance law by adding sections about autism coverage (sections were eventually added and are summarized at the bottom of this page under “Delaware Parity Law,” “Autism Coverage”). Here is how this bill is different than what is currently in the law:
Content Disclaimer: Parity Track is a collaborative forum that works to aggregate and elevate the parity implementation work taking place across the country. The content of this website is always evolving. If you are aware of other parity-related work that is not represented on this website, please contact us so that we can continue to improve this website.